Depression and heart disease

Depression and Anxiety

Volumn 7, Issue 4, 1998, Pages 158-165

  Roose, Steven P ^a   Spatz, Erica ^b  

^a Columbia University ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; DESIPRAMINE; DOXEPIN; FLECAINIDE; FLUOXETINE; IMIPRAMINE; MORACIZINE; NORTRIPTYLINE; PAROXETINE; QUINIDINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG SAFETY; HEART CONDUCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MENTAL DISEASE; MORTALITY; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANTIDEPRESSIVE AGENTS; COMORBIDITY; DEPRESSIVE DISORDER; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0031847489     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1998)7:4<158::AID-DA3>3.0.CO;2-6     Document Type: Article

References (64)

1. Malzberg B (1937) Mortality among patients with involutional melancholia. Am J Psychiatry 93:1231-1238.
2. Black DW, Warrack G, Winokur G (1985) The Iowa record-linkage study: III. Excess mortality among patients with "functional" disorders. Arch Gen Psychiatry 42:82-88.
3. Weeke A (1979) Causes of death in manic-depressives. In Schou M, Stromgren E (eds): Origin, Prevention and Treatment of Affective Disorders. London: Academic Press, pp 289-299.
4. Murphy JM, Monson RR, Olivier DC, Sobol AM, Leighton AH (1987) Affective disorders and mortality. A general population study. Arch Gen Psychiatry 44:473-480.
5. Rabins PV, Harvis K, Koven S (1985) High fatality rates of late-life depression associated with cardiovascular disease. J Affect Disord 9:165-167.
6. Weeke A, Vaeth M (1986) Excess mortality of bipolar and unipolar manic-depressive patients. J Affect Disord 11:227-234.
7. Avery D, Winokur G (1976) Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry 33.1029-1037.
8. Glassman AH, Helzer JE, Covey LS (1990) Smoking, smoking cessation, and major depression. JAMA 264:1546-1549.
9. Aromaa A, Raitasalo R, Reunanen A, et al. (1994) Depression and cardiovascular diseases. Acta Psychiatr Scand Suppl 377: 77-82.
10. Everson SA, Goldberg DE, Kaplan GA (1996) Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med 58:113-121.
11. Barefoot JC, Schroll M (1996) Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 93:1976-1980.
12. Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW (1996) Depression, psychotropic medication, and risk of myocardial infarction: Prospective data from the Baltimore ECA Follow-up. Circulation 94:3123-3129.
13. Vogt T, Pope C, Mullooly J, Hollis J (1994) Mental health status as a predictor of morbidity and mortality: A 15-year follow-up of members of a health maintenance organization. Am J Public Health 84:227-231.
14. Ford DE, Mead LA, Chang PP, Levine DM, Klag MJ (1994) Depression predicts cardiovascular disease in men: The precursors study. Circulation 90, Pt 2, Oct. I-614 (Abstract).
15. Carney RM, Rich MW, Freedland KE (1988) Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 50:627-633.
16. Schleifer SJ, Macari-Hinson MM, Coyle DA (1989) The nature and course of depression following myocardial infarction. Arch Intern Med 149:1785-1789.
17. Ladwig KH, Kieser M, Konig J, Breithardt G, Borggrefe M (1991) Affective disorders and survival after acute myocardial infarction: Results from the post-infarction late potential study. Eur Heart J 12:959-964.
18. Frasure-Smith N, Lesperance F, Talajic M (1993) Depression following myocardial infarction: Impact on 6-month survival. JAMA 270:1819-1825.
19. Frasure-Smith N, Lesperance F, Talajic M (1995) Depression and 18-month prognosis after myocardial infarction. Circulation 91:999-1005.
20. Carney RM, Rich MW, Tevelde A, Saini J, Clark K, Freedland KE (1988) The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res 32:159-164.
21. Yeragani VK, Pohl RB, Balon R (1991) Heart rate variability in patients with major depression. Psychiatry Res 37:35-46.
22. Roose SP, Dalack GW (1992) Treating the depressed patient with cardiovascular problems. J Clin Psychiatry 53 (Sep Suppl):25-31.
23. Lown B, DeSilva RA, Reich P, Murawski BJ (1980) Psychophysiologic factors in sudden cardiac death. Am J Psychiatry 137:1325-1335.
24. Lown B (1987) Sudden cardiac death: Biobehavioral perspective. Circulation 76:1186-1196.
25. Kliks BR, Burgess MJ, Abildskov JA (1975) Influence of sympathetic tone on ventricular fibrillation threshold during experimental coronary occlusion. Am J Cardiol 36:45-49.
26. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ, Multicenter Post-Infarction Research Group (1987) Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59:256-262.
27. Glassman AH, Bigger JT Jr, Giardina EGV, Kantor SJ, Perel JM, Davies M (1979) Clinical characteristics of imipramine-induced orthostatic hypotension. Lancet 1:468-472.
28. Muller OF, Goodman N, Bellet S (1961) The hypotensive effect of imipramine hydrochloride in patients with cardiovascular disease. Clin Pharmacol Ther 2:300-307.
29. Hayes JR, Born GF, Rosenbaum AH (1977) Incidence of orthostatic hypotension in patients with primary affective disorders treated with tricyclic antidepressants. Mayo Clin Proc 52:509-512.
30. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ III (1987) Psychotropic drug use and the risk of hip fracture. N Engl J Med 316:363-369.
31. Giardina EGV, Bigger JT Jr, Glassman AH (1983) Desmethylimipramine and imipramine on left ventricular function and the ECG: A randomized crossover design. Int J Cardiol 2:375-385.
32. Kopera H (1978) Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo. Br J Clin Pharmacol 5 (Suppl. 10):29s-34s.
33. Roose SP, Dalack GW, Glassman AH, Woodring S, Walsh BT, Giardina EGV (1991) Is doxepin a safer tricyclic for the heart? J Clin Psychiatry 52:338-341.
34. Roose SP, Glassman AH, Siris SG, Walsh BT, Bruno RL, Wright LB (1981) Comparison of imipramine-and nortriptyline-induced orthostatic hypotension: A meaningful difference. J Clin Psychopharmacol 1:316-319.
35. Thayssen P, Bierre M, Kragh-Sorensen P (1981) Cardiovascular effects of imipramine and nortriptyline in elderly patients. Psychopharmacology 74:360-364.
36. Glassman AH, Johnson LL, Giardina EGV (1983) The use of imipramine in depressed patients with congestive heart failure. JAMA 250:1997-2001.
37. Roose SP, Glassman AH, Giardina EGV (1986) Nortriptyline in depressed patients with left ventricular impairment. JAMA 256.3253-3257.
38. Glassman AH, Roose SP, Giardina EGV, Bigger JT Jr. (1987) Cardiovascular effects of tricyclic antidepressants. In Meltzer HY (ed): Psychopharmacology: The Third Generation of Progress. New York: Raven Press, pp 1437-1442.
39. Constantino EA, Roose SP, Woodring S (1993) Tricyclic-induced orthostatic hypotension. Significant difference in depressed and nondepressed states. Pharmacopsychiatry 26:125-127.
40. Kantor SJ, Glassman AH, Bigger JT Jr, Perel JM, Giardina EGV (1978) The cardiac effects of therapeutic plasma concentrations of imipramine. Am J Psychiatry 135:534-538.
41. Glassman AH, Bigger JT Jr. (1981) Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review. Arch Gen Psychiatry 38:815-820.
42. Vohra J, Burrows GD, Hunt D, Sloman G (1975) The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction. Eur J Cardiol 3:219-227.
43. Weld FM, Bigger JT Jr. (1980) Electrophysiological effects of imipramine on ovine cardiac Purkinje and ventricular muscle fibers. Circ Res 46:167-175.
44. Rawling DA, Fozzard HA (1979) Effects of imipramine on cellular electrophysiological properties of cardiac Purkinje fibers. J Pharmacol Exp Ther 209:371-375.
45. Roose SP, Glassman AH, Giardina EGV, Walsh BT, Woodring S, Bigger JT Jr. (1987) Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry 44:273-275.
46. Dalack GW, Roose SP, Glassman AH (1991) Tricyclics and heart failure (Letter). Am J Psychiatry 148:1601.
47. Williams RB Jr, Sherter C (1971) Cardiac complications of tricyclic antidepressant therapy. Ann Intern Med 74:395-398.
48. Bigger JT Jr., Giardina EGV, Perel JM, Kantor SJ, Glassman AH (1977) Cardiac antiarrhythmic effect of imipramine hydrochloride. N Engl J Med 296:206-208.
49. Giardina EGV, Barnard JT, Johnson LL, Saroff AL, Bigger JT Jr., Louie M (1986) The antiarrhythmic effect of nortriptyline in cardiac patients with ventricular premature depolarizations. J Am Coll Cardiol 7:1363-1369.
50. Glassman AH, Roose SP, Bigger JT Jr. (1993) The safety of tricyclic antidepressants in cardiac patients: Risk/benefit reconsidered. JAMA 269:2673-2675.
51. Furberg CD (1983) Effect of antiarrhythmic drugs on mortality after myocardial infarction. Am J Cardiol 52:32C-36C.
52. Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406-412.
53. Cardiac Arrhythmia Suppression Trial II Investigators (1992) Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 327:227-233.
54. Selzer A, Wray HW (1964) Quinidine syncope: paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias. Circulation 30:17-26.
55. Falk RH (1989) Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation. Ann Intern Med 111:107-111.
56. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC (1990) Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized control trials. Circulation 82:1106-1116.
57. Bigger JT Jr. (1990) Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment. Am J Cardiol 65:3D-10D.
58. Echt DS, Liebson PR, Mitchell LB (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324:781-788.
59. Greenberg HM, Dwyer EM Jr, Hochman JS, Steinberg JS, Echt DS, Peters RW (1995) Interaction of ischaemia and encainide/flecainide treatment: A proposed mechanism for the increased mortality in CAST I. Br Heart J 74:631-635.
60. Roose SP, Dalack GW, Glassman AH, Woodring S, Walsh BT, Giardina EGV (1991) Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry 148:512-516.
61. Roose SP, Glassman AH, Attia E, Woodring S, Giardina EGV, Bigger JT Jr. (1998) Cardiovascular effects of fluoxetine in depressed patients with heart disease. A mJ Psychiatry 155:660-665.
62. Roose SP, Laghrissi-Thode F, Kennedy JS (1998) Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279:287-291.
63. Shapiro PA, Glassman AH, Lesperance F (1996) Treatment of major depression after acute myocardial infarction with sertraline: A preliminary study. Proceedings of the American Psychiatric Association, New Research. New York, pp 249-250.
64. Roose SP, Glassman AH, Attia E, Woodring S (1994) Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 151:1735-1739.